LabRoots invites you to the 3rd Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation of the abilities of CRISPR-based editing, next-gen editing tools, precision in gene editing, and using CRISPR for drug discovery.
The planning committee will bring together thought leaders from academia, trained researchers from clinical laboratories, and industry experts from pharmaceutical to biotech. Experts will share case studies, experiences, and new developments regarding best practices and address appropriate alternatives that are currently being developed.
CRISPR Applications in Biomedicine and Agriculture
CRISPR for Addressing COVID-19 Pandemic
Ethical, Social, and Legal Issues in CRISPR applications
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2019 conference, this event will be produced on our robust platform, allowing you to watch, learn, and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 CRISPR Virtual Event. Submission is free. Submit your abstract here.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Use #LRcrispr to follow the conversation!
Fellow, McGovern Institute for Brain Research at MIT
Head of Business for EMEA, Merck KGaA
Product Manager at Horizon Discovery
Fellow, McGovern Institute for Brain Research at MIT
Sr. Staff Scientist
VP Applications Development, Inscripta
Assistant Member, Center for Advanced Genome Engineering (CAGE), St. Jude Children's Research Hospital, Department of Cell and Molecular Biology
Managing Director of the Genome Editing Core Facility; Rutgers Cancer Institute of New Jersey
Laboratory of Dr. Richard Sherwood Division of Genetics, Brigham and Women's Hospital and Harvard Medical School
At MicroGEM, we have re-invented nucleic acid extraction. We replace traditional extraction methods with a temperature-driven, enzymatic approach, enabling high-quality extracts from low abundance transcripts and small sample volumes. Leveraging our prepGEM Universal thermophilic ...See more See less
Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results. By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to ...See more See less
Millipore Sigma is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis ...See more See less
GenScript is the leading gene, peptide, protein and antibody research partner for fundamental life science research, translational biomedical research, and early stage pharmaceutical development. Since our establishment in 2002, GenScript has exponentially grown to become a ...See more See less
Horizon Discovery Group PLC is a world leader in the utilization of gene editing and gene modulation technologies to support the greater understanding of gene function, the genetic drivers behind human disease and the development of molecular, cell and gene therapies to enable ...See more See less
Inscripta is developing the world's first benchtop platform for scalable digital genome engineering. The company's advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel ...See more See less
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors ("Cardean transistors"). Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical ...See more See less
For over 30 years, IDT has enabled discovery by adhering to the highest manufacturing standards, even as we continue to lower prices and improve delivery speed. Our full-workflow CRISPR solutions include potent Cas9 and Cas12a nucleases (for GC-rich or AT-rich genomes), custom ...See more See less
With a portfolio of more than 4,000 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists in ...See more See less
OriGene Technologies was founded as a research tool company focused on the creation of the large commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based ...See more See less
As the scientific community races to solve this evolving global health crisis, Twist Bioscience is proud to carry on as an active partner for all of your research needs. Twist's unique silicon-based DNA writing platform allows for the rapid development of NGS panels for viral ...See more See less
PacBio® delivers highly accurate long-read sequencing for the most comprehensive view of human genetic variation. Our Sequel® IIe System provides the benefits of HiFi sequencing for deeper biological insights quickly and affordably. PacBio's end-to-end solutions include whole ...See more See less
Dr. Manush Saydmohammed is currently Research Instructor at the University of Pittsburgh, PA. Prior to this, he worked as Research Associate at Uniformed Services University of the Health Sciences, Bethesda MD and as Japan Society for Promotional Sciences Post Doctoral Fellow at ...See more See less
Dr. Muhamuda Kader, an immunologist by background, is currently working as a Research Faculty at the University of Pittsburgh, PA. After her bachelor's and master's in microbiology, and Ph.D in Neurovirology from the National Institute of Mental Health and Neuroscience ...See more See less